Perioperative Management of the Patient with Endocrine Disease: A Focus on Diabetes & Thyroid Dysfunction
|
|
- Lester Hodge
- 5 years ago
- Views:
Transcription
1 Perioperative Management of the Patient with Endocrine Disease: A Focus on Diabetes & Thyroid Dysfunction Luigi Meneghini, MD, MBA Professor, Internal Medicine (Endocrinology), UT Southwestern Medical Center Executive Director, Global Diabetes Program, Parkland Health & Hospital System
2 Advisory Board: Novo Nordisk, Sanofi, Intarcia Consultant: Sanofi Dyaeli Kunkel wife, mother of my children & rock of my life
3 Perioperative Diabetes Management
4 Increased mortality with increasing mean BG after CABG (coronary artery bypass) Mortality % Post-CABG Cardiac-related mortality Noncardiac-related mortality 2 0 < > 250 Average Postoperative Glucose (mg/dl) Furnary et al. J Thorac Cardiovasc Surg. 2003;125:
5 Lower mortality after CABG using IV 10 insulin for BG control Mortality (%) IV Insulin Protocol Patients with diabetes Patients without diabetes Year Furnary AP et al. J Thorac Cardiovasc Surg. 2003;125:
6 More complication in patients with diabetes after non-cardiac surgery 14% Diabetes Non-DM 12% 10% 8% 6% 4% 2% 0% Death Pneumonia* Wound * P < 0.05 infection* Sepsis/bact* UTI* AMI* ARF* Frisch, et al. Diabetes Care 2010; 33:
7 Recommendations regarding pre-operative A1C and peri-operative glycemic control
8 A1C > 8% associated with increased hospital LOS independent of perioperative glucose Hospital LOS (days) 30-d mortality (%) Wound infection (%) Controls 6.5% % % > 10% Pre-op A1C levels of patients with diabetes Only 1/3 of patients had an A1C w/in 90 days of surgery Underwood P, et al. Diabetes Care 2014;37:
9 Perioperative glycemic control, but not A1C predicts 30-day mortality post-op Non-cardiac surgery (n=6684) Cardiac surgery (6393) Mean perioperative glucose (mg/dl Mean perioperative glucose (mg/dl Preoperative A1C was good predictor of perioperative glycemic control Van den Boom, et al. Diabetes Care Feb 13. pii: dc doi: /dc [Epub ahead of print]
10 What A1C level is acceptable for elective surgeries? < 8.5% if it is safe to do so
11 Perioperative target blood glucose should be mg/dl up to 216 mg/dl acceptable mg/dl mg/dl < 180 mg/dl Beyond avoidance of marked hyperglycemia and hypoglycemia, the optimal perioperative glucose targets are unclear Dhatariya, et al. Diabetic Medicine 2012; 29: ADA Standards. Diabetes Care 2017; 40: S1-S136
12 Which diabetic therapies should you omit the day of surgery?
13 Outpatient pre-operative glycemic management: patient instructions Hold oral anti-diabetic agents the morning of surgery Hold non-insulin injectables the morning of surgery Hold rapid-acting (prandial) insulin the morning of surgery Adjust the basal insulin
14 Physiologic Insulin Replacement
15 Concept of basal bolus insulin Rx 325 BID options NPH Levemir QD options Glargine U100 Degludec Glargine U300 Regular Aspart/Lispro/Glulisine Faster-acting aspart Regular Aspart/Lispro/Glulisine Faster-acting aspart
16 Physiologic insulin secretion & replacement Basal Mealtime Corrective
17 Parkland perioperative insulin management protocol: initial prescription Total Daily Dose (TDD) 0.5 or 0.3 u/kg/day Take into account age, weight & renal function Total BASAL dose 50% of TDD Total PRANDIAL dose 50% of TDD NPH or Detemir twice daily Glargine or Degludeconce daily Distribute with meals Regular, Aspart, Lispro, Glulisine 3 times daily 56 y/o T2D Weight 96kg egfr > 60 cc/min TDD 0.5 u/kg/d x 96kg 48 units Basal 50% of units daily Prandial 50% of 48 3 meals 8 units QAC Odedosu K, et al. Submitted for presentation at ADA 2018
18 Basal insulin adjustments pre-operatively Night/evening before surgery Morning/day of surgery Intermediate-acting (NPH) Long-acting (Glargine, Detemir, Degludec) Premix (70/30, 75/25) 20% 50% 20% 50% Society of Hospital Medicine. 2015
19 What criteria should you use for using IV (intravenous) insulin versus SQ (subcutaneous) insulin perioperatively?
20 Intra-operative insulin management: IV or SQ? Duration of surgery Complexity of surgery: CABG, organ transplant, prolonged neurosurgical
21 Perioperative and intraoperative blood glucose monitoring Subcutaneous Intravenous Parkland Intraoperative insulin protocol Q 2-4 hours Q 1-2 hours Use rapid-acting analog for correction Use Regular insulin for correction
22 Transitioning to post-op glycemic management Subcutaneous Intravenous 325
23 Parkland perioperative insulin protocol Global Diabetes Program Perioperative Insulin Management Protocol Quality Improvement Initiative with Hospitalist U Team (Limb Salvage Team) Inpatient Podiatry Service HOSPITAL MEDICINE SURGERY ANESTHESIA PHARMACY NURSING INFORMATION TECHNOLOGY
24 Perioperative management of thyroid dysfunction
25 Perioperative complications of thyroid dysfunction Hypothyroidism Hypotension under anesthesia Ventilatory dysfunction Fluid & electrolyte disturbances Decreased clearance of anesthetics, tranquilizers & narcotics Post-operative ileus Anemia Myxedema coma Hyperthyroidism Cardiac arrhythmias Fever Gastrointestinal disturbances Thyroid storm High output heart failure Mental status changes
26 Preoperative screening for thyroid dysfunction Routine screening is not recommended However, if there is suspicion of thyroid dysfunction because of Symptoms Unexplained weight changes Palpitations Tremors Changes in bowel habits, skin or hair Skin abnormalities TSH Physical exam Exophthalmos Goiter Abnormal reflexes Hair/skin abnormalities Tachycardia or bradycardia
27 Diagnosis of HYPOthyroidism Central hypothyroidism TSH = serum free T4 Primary hypothyroidism (95% of cases) serum free T4 = TSH
28 Preparing the HYPOthyroid patient for surgery Pre-op Immediate pre-op Post-op Normalize TSH Continue LT4 LT4 1.6 mcg/kg/day (Elderly or CAD start 25 mcg/d) If NPO 5d, consider IV LT4 (Use 60-80% of oral dose) Severe hypothyroidism requiring urgent surgery Loading dose IV LT mcg + Consider stress dose CCS Dexamethasone 4mg IV bolus Daily dose IV LT mcg Bennet-Guerrero et al. Anesth Analg 1997; 85: Stahatos et al. Endocrinol Metab Clin North Am 2003; 32:
29 Diagnosis of HYPERthyroidism Central hyperthyroidism (rare) TSH = serum free T4 Primary hyperthyroidism serum free T4 = TSH
30 Preparing the HYPERthyroid patient for surgery Pre-op Immediate pre-op Post-op Overt disease Normalize TSH Mild/subclinical Beta-blockers Continue Thionamides If NPO may administer rectally Thionamides 3-8 weeks Beta-blockers Potassium iodide for Graves Severe hyperthyroidism requiring urgent surgery Intravascular hemodynamic monitoring Thionamides + beta-blockade Inorganic iodide Glucocorticoid Cholestyramine Glucocorticoid taper Thionamides = methimazole or propylthiouracil Ross, et al. Thyroid 2016 Oct;26(10):
31 Indications for surgical treatment of toxic goiter Parathyroid Adenoma Large thyroid size ( 80 g) Upper airway obstruction or dysphagia Graves ophthalmopathy Persistent hyperthyroidism following antithyroid meds & RAI Concomitant primary hyperparathyroidism Ross, et al. Thyroid 2016 Oct;26(10):
32 Preparing for removal of toxic goiter Pre-op Immediate pre-op Post-op Normalize TSH Thionamides 3-8 weeks Beta-blockers Potassium iodide for Graves Check &/or replete Calcium &/or 25-OH vit D Check calcium & ipth Stop thionamides Taper beta-blockers Replace LT4 Urgent surgery Intravascular hemodynamic monitoring Thionamides + beta-blockade Inorganic iodide Glucocorticoid Cholestyramine Glucocorticoid taper Thionamides = methimazole or propylthiouracil Ross, et al. Thyroid 2016 Oct;26(10):
33
9/23/09. What are the key components of preoperative, intraoperative, & postoperative care of diabetes management? Rebecca L. Sturges, M.D.
RMHS Perioperative Summit: Perioperative Diabetes Management Rebecca L. Sturges, M.D. Oct 6, 2009 Mrs. B was referred by her orthopedic surgeon to your preoperative clinic to discuss medical management
More informationInpatient and perioperative management of hyperglycemia
Inpatient and perioperative management of hyperglycemia Department of Internal Medicine Grand Rounds July 7, 2017 Luigi Meneghini discloses that he has served on advisory boards and as consultant for both
More informationInpatient Management of Hyperglycemia Guillermo Umpierrez, MD, CDE Saturday, February 10, :30 a.m. 11:15 a.m.
Inpatient Management of Hyperglycemia Guillermo Umpierrez, MD, CDE Saturday, February 1, 218 1:3 a.m. 11:15 a.m. There are over 7.5 million hospital admissions for patients with diabetes in the US. About
More informationInpatient Management of Hyperglycemia Guillermo Umpierrez, MD, CDE Saturday, February 10, :30 a.m. 11:15 a.m.
Inpatient Management of Hyperglycemia Guillermo Umpierrez, MD, CDE Saturday, February 10, 2018 10:30 a.m. 11:15 a.m. There are over 7.5 million hospital admissions for patients with diabetes in the US.
More informationNon Thyroid Surgery. In patients with Thyroid disorders
Non Thyroid Surgery In patients with Thyroid disorders The Thyroid disease problem. Is Thyroid disease a problem with anaesthetic? Why worry? The Physiology The evidence. A pragmatic approach From: The
More informationSpecial Situations 1
Special Situations 1 Outline Continuous Nutrition Tube feeds TPN Steroids Pumps Perioperative BG Control 2 Patient receiving continuous TF or TPN Continuous nutrition coverage options: Analog q4hr Regular
More informationHAP PA-HEN Achieving More Together
HAP PA-HEN Achieving More Together Managing Hyperglycemia in the Hospital: Strategies for Safe and Effective Care Pennsylvania Patient Safety Authority Managing Hyperglycemia in the Hospital: Strategies
More informationInpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin
Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin David Newman, MD University of North Dakota School of Medicine Sanford Health Big Sky Conference 2017 Dr. David Newman, Personal/Professional
More informationMixed Insulins Pick Me
Mixed Insulins Pick Me Alvin Goo, PharmD Clinical Associate Professor University of Washington School of Pharmacy and Department of Family Medicine Objectives Critically evaluate the evidence comparing
More informationPerioperative Decision Making The decision has been made to proceed with operative management timing and site of surgery the type of anesthesia preope
Preoperative Evaluation In Endocrine Disorders Dr Nahid Zirak 2012 Perioperative Decision Making The decision has been made to proceed with operative management timing and site of surgery the type of anesthesia
More informationLearning Objectives. Perioperative SWEET Success
Perioperative SWEET Success PERIOPERATIVE SWEET SUCCESS PRESENTED BY: KENDRA MARTIN, RN, BSN, CDE JENNIFER SIMPSON, RN, BC-ADM, MSN, CNS Disclosure to Participants Notice of Requirements For Successful
More informationNewer Insulins. Boca Raton Regional Hospital 15th Annual Internal Medicine Conference
Newer Insulins Boca Raton Regional Hospital 15th Annual Internal Medicine Conference Luigi F. Meneghini, MD, MBA Professor of Internal Medicine, UT Southwestern Medical Center Executive Director, Global
More informationDeepika Reddy MD Department of Endocrinology
Deepika Reddy MD Department of Endocrinology Management of hyperglycemic crisis Review need for inpatient glycemic control Brief overview of relevant trials Case based review of diabetes management strategies/review
More informationIn-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University
In-Hospital Management of Diabetes Dr Benjamin Schiff Assistant Professor McGill University No conflict of interest to declare CLINICAL SCENARIO 62 y/o male with hx of DM 2, COPD, and HT is admitted with
More informationGlycemic Control Insulin In The Hospital Setting
Glycemic Control Insulin In The Hospital Setting Glycemic Control The Evidence For Insulin s s Benefit The Mechanism of Insulin s s Benefit The Achievement of Insulin s s Benefit A Few Cases Hyperglycemia
More informationInpatient Glycemic Management 2016
2016 Jim Chamberlain MD Medical Director for Diabetes Services St. Mark s Hospital and St. Mark s Diabetes Center Salt Lake City, Utah Disclosures Speakers Bureaus Merck & Co. Janssen Pharmaceutical Companies
More informationW. Heath Giles, M.D. University of Tennessee College of Medicine Chattanooga Assistant Professor of Surgery Associate Residency Program Director
W. Heath Giles, M.D. University of Tennessee College of Medicine Chattanooga Assistant Professor of Surgery Associate Residency Program Director It is our duty to each learner to honor your right to expect
More informationDiabetic Ketoacidosis
October 2015 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Case History HPI: 24 yo man with recent 8 lb. weight loss, increased thirst and frequent
More informationInpatient Management of Diabetes Mellitus. Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy
Inpatient Management of Diabetes Mellitus Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy 2 Disclosure Jessica Garza does not have any actual or potential conflicts of
More informationLet s not sugar coat it: Promoting excellence in glucose control in hospitalized and perioperative patients WELCOME!
Let s not sugar coat it: Promoting excellence in glucose control in hospitalized and perioperative patients WELCOME! 1. Evaluate the evidence for variable glycemic control for patients in the hospital
More informationInsulin Regimens: Hitting Glycemia Targets
Insulin Regimens: Hitting Glycemia Targets Grant Kelley MD March 1 st, 2018 Faculty Disclosure: Financial relationships with commercial interests None Overview Mortality and Morbidity Insulin and Insulin
More informationImproving Glycemic Control in the Critical Care
Improving Glycemic Control in the Critical Care Setting /Hospitalists Outline Review current guidelines Review current glycemic targets DKA Treatment Building a perfect glycemic control protocol Transition
More informationBasal Bolus Insulin Therapy Frequently Asked Questions
1. What is Basal Bolus Insulin Therapy (BBIT)? 2. What evidence supports the use of subcutaneous Basal Bolus Insulin Therapy? 3. Does Basal Bolus Insulin Therapy apply to all patients? 4. What s wrong
More informationInsulin Initiation and Intensification. Disclosure. Objectives
Insulin Initiation and Intensification Neil Skolnik, M.D. Associate Director Family Medicine Residency Program Abington Memorial Hospital Professor of Family and Community Medicine Temple University School
More informationUpdate on Insulin-based Agents for T2D. Harry Jiménez MD, FACE
Update on Insulin-based Agents for T2D Harry Jiménez MD, FACE Harry Jiménez MD, FACE Has received honorarium as Speaker and/or Consultant for the following pharmaceutical companies: Eli Lilly Merck Boehringer
More informationUKPDS: Over Time, Need for Exogenous Insulin Increases
UKPDS: Over Time, Need for Exogenous Insulin Increases Patients Requiring Additional Insulin (%) 60 40 20 Oral agents By 6 Chlorpropamide years, Glyburide more than 50% of UKPDS patients required insulin
More informationTransition of Care in Hospitalized Patients with Hyperglycemia and Diabetes
Transition of Care in Hospitalized Patients with Hyperglycemia and Diabetes Critically ill patients in the ICU Hospital Non-ICU Settings Home Guillermo E Umpierrez, MD, FACP, FACE Professor of Medicine
More informationDiabetes confers an increased risk of perioperative
LUIGI F. MENEGHINI, MD, MBA Associate Professor of Clinical Medicine and Director of Clinical Operations, Division of Endocrinology, Diabetes and Metabolism, University of Miami Health System and University
More informationSociety for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery
Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia
More informationPosition Statement of ADA / EASD 2012
Management of Hyperglycemia in Type2 Diabetes: A Patient- Centered Approach Position Statement of ADA / EASD 2012 Cause of : Type 2 diabetes Cardiovascular disorders Blindness End-stage renal failure Amputations
More informationAPPENDIX American Diabetes Association. Published online at
APPENDIX 1 INPATIENT MANAGEMENT OF TYPE 2 DIABETES No algorithm applies to all patients with diabetes. These guidelines apply to patients with type 2 diabetes who are not on glucocorticoids, have no
More informationImplementing Hospital Policies & Protocols
Implementing Hospital Policies & Protocols Jane Jeffrie Seley DNP MPH GNP BC-ADM CDE CDTC FAADE FAAN Division of Endocrinology, Diabetes & Metabolism NewYork-Presbyterian Hospital Weill Cornell Medicine
More informationInitiating Injectable Therapy in Type 2 Diabetes
Initiating Injectable Therapy in Type 2 Diabetes David Doriguzzi, PA C Learning Objectives To understand current Diabetes treatment guidelines To understand how injectable medications fit into current
More informationDEMYSTIFYING INSULIN THERAPY
DEMYSTIFYING INSULIN THERAPY ASHLYN SMITH, PA-C ENDOCRINOLOGY ASSOCIATES SCOTTSDALE, AZ SECRETARY, AMERICAN SOCIETY OF ENDOCRINE PHYSICIAN ASSISTANTS ARIZONA STATE ASSOCIATION OF PHYSICIAN ASSISTANTS SPRING
More informationMartin J Stevens MD, FRCP, Endocrinologist and Professor of Medicine
The Approach to Inpatient Hyperglycemia Martin J Stevens MD, FRCP, Endocrinologist and Professor of Medicine Great Lakes Hospital Medical Symposium May 7th 2010 Further Increases in the Prevalence of Diabetes
More informationUpdate on Insulin-based Agents for T2D
Update on Insulin-based Agents for T2D Injectable Therapies for Type 2 Diabetes Mellitus (T2DM) and Obesity This presentation will: Describe established and newly available insulin therapies for treatment
More informationTimely!Insulinization In!Type!2! Diabetes,!When!and!How
Timely!Insulinization In!Type!2! Diabetes,!When!and!How, FACP, FACE, CDE Professor of Internal Medicine UT Southwestern Medical Center Dallas, Texas Current Control and Targets 1 Treatment Guidelines for
More informationAgenda. Indications Different insulin preparations Insulin initiation Insulin intensification
Insulin Therapy F. Hosseinpanah Obesity Research Center Research Institute for Endocrine sciences Shahid Beheshti University of Medical Sciences November 11, 2017 Agenda Indications Different insulin preparations
More informationOptimizing Care of the Inpatient with Hyperglycemia and Diabetes: Case Studies in Action
Optimizing Care of the Inpatient with Hyperglycemia and Diabetes: Case Studies in Action Learning Objectives Identify patient situations where specific attention to glycemic control is warranted Determine
More informationClinicalTrials.gov Identifier: sanofi-aventis. Sponsor/company:
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinicalTrials.gov
More informationInpatient Glycemic Management:
Disclosure to Participants Conflict of Interest (COI) and Financial Relationship Disclosures: Dr. Seley attended Advisory Board Meeting: Alliance (Boehringer-Ingelheim/Lilly) Bayer Diabetes Care Sanofi
More informationEvidence for Basal Bolus Insulin Versus Slide Scale Insulin
Curr Emerg Hosp Med Rep (2014) 2:26 34 DOI 10.1007/s40138-013-0032-4 DIABETES AND METABOLIC DISEASE (W FORD, SECTION EDITOR) Evidence for Basal Bolus Insulin Versus Slide Scale Insulin Sameer Badlani William
More informationInsulin Prior Authorization with optional Quantity Limit Program Summary
Insulin Prior Authorization with optional Quantity Limit Program Summary 1-13,16-19, 20 FDA LABELED INDICATIONS Rapid-Acting Insulins Humalog (insulin lispro) NovoLog (insulin aspart) Apidra (insulin glulisine)
More informationFaculty. Timothy S. Reid, MD (Co-Chair, Presenter) Medical Director Mercy Diabetes Center Janesville, WI
Activity Overview In this case-based webcast, meet Jackie, a 62-year-old woman with type 2 diabetes. Her glycated hemoglobin (HbA1C) is 9.2%, and she is taking 2 oral agents and basal insulin; however,
More informationΑναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς
Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς Αναστασία Θανοπούλου Επίκουρη Καθηγήτρια Β Παθολογικής Κλινικής Πανεπιστημίου Αθηνών Διαβητολογικό Κέντρο, Ιπποκράτειο Νοσοκομείο
More informationThe Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It
The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It Cassie Brady, MD Assistant Professor of Pediatrics Division of Endocrinology and Diabetes Monroe Carell Junior Children s Hospital
More information5/15/2018 DISCLOSURE OBJECTIVES. FLORIDA HOSPITAL ORLANDO Not for profit organization Acute care medical center 1,368 licensed beds BACKGROUND
DISCLOSURE PHARMACIST DIRECTED MANAGEMENT OF GLUCOCORTICOID INDUCED HYPERGLYCEMIA AT A LARGE COMMUNITY HOSPITAL Jill Zaccardelli, PharmD PGY1 Pharmacy Resident Florida Hospital Orlando Jill.Zaccardelli@flhosp.org
More informationNph insulin conversion to lantus
Nph insulin conversion to lantus Search 26-2-2003 RESPONSE FROM AVENTIS. We appreciate the opportunity to respond to Dr. Grajower s request for information regarding Lantus ( insulin glargine [rdna origin.
More informationObjectives. Medical Complications of Pregnancy. Potential Conflicts: None. Common Complicating Medical Conditions that Precede Pregnancy
Medical Complications of Potential Conflicts: None Ellen W. Seely, M.D. Director of Clinical Research Endocrine-Hypertension Division Brigham and Women s Hospital Professor of Medicine Harvard Medical
More informationEndocrinology Emergencies & Glycemic Control in the ICU
Endocrinology Emergencies & Glycemic Control in the ICU Mark Franklin, MD Dartmouth-Hitchcock Medical Center - Lebanon, NH Avera Health eicu - Sioux Falls, SD Objectives Recognize and understand the treatment
More informationGlucose Management in NON-ICU Hospitalized Patients
Glucose Management in NON-ICU Hospitalized Patients October 15, 2016 Archana R. Sadhu, MD., FACE Director of System Diabetes Program Director of Transplant Endocrinology Assistant Professor, Weill Cornell
More informationEndocrine Crises. Fred Pieracci, MD, MPH TACS Fellow
Endocrine Crises Fred Pieracci, MD, MPH TACS Fellow 4.14.14 Endocrine Crises Rare Highly lethal Elusive Easily treatable 1. Thyroid 1. Thyroid storm 2. Myxedema coma Outline 2. Parathyroid: 1. Severe hypercalcemia
More informationEndocrine and Metabolic Disorders. Zalak Patel, MBBS Anesthesiology and Perioperative Medicine Medical College of Georgia Augusta University 2016
Endocrine and Metabolic Disorders Zalak Patel, MBBS Anesthesiology and Perioperative Medicine Medical College of Georgia Augusta University 2016 Metabolic Syndrome Diagnosis requires at least three of
More informationGlucose Management in Noncritical Hospitalized Patients
Glucose Management in Noncritical Hospitalized Patients October 17, 2015 Archana R. Sadhu, MD., FACE Director of System Diabetes Program Director of Transplant Endocrinology Assistant Professor, Weill
More informationHyperthyroidism. Objectives. Clinical Manifestations. Slide 1. Slide 2. Slide 3. Implications for Primary Care. hyperthyroidism
1 Hyperthyroidism Implications for Primary Care Laura A. Ruby, DNP, CRNP Wellspan Endocrinology 2 Objectives! Discuss the clinical manifestations of hyperthyroidism! Review the use of the diagnostic studies!
More informationMedically Compromised Patients (Part II)
Medically Compromised Patients (Part II) Ra ed Salma BDS, MSc, JBOMFS, MFDRCSI Endocrine Disorders I. Diabetes Mellitus (DM) Definition (WHO): - Chronic disease due to absolute or relative lack of insulin
More informationIndividualizing Care for Patients with Type 2 Diabetes
Individualizing Care for Patients with Type 2 Diabetes Disclosures Speaker: AstraZeneca, Novo Nordisk, BI/Lilly, Valeritas, Takeda Advisor: Tandem Diabetes, Sanofi Objectives Develop individualized approaches
More informationIn - Hospital Diabetes Care. A review and personal experience
In - Hospital Diabetes Care A review and personal experience Hyperglycemia in the Hospital The Problem Hospitalizations with Diabetes http://www.cdc.gov/diabetes/statistics/dmany/fig1.htm Prevalence of
More informationType 2 Diabetes Mellitus Insulin Therapy 2012
Type 2 Diabetes Mellitus Therapy 2012 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Preparations Onset Peak Duration
More informationComprehensive Diabetes Treatment
Comprehensive Diabetes Treatment Joshua L. Cohen, M.D., F.A.C.P. Professor of Medicine Interim Director, Division of Endocrinology & Metabolism The George Washington University School of Medicine Diabetes
More informationTips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital
Tips and Tricks for Starting and Adjusting Insulin MC MacSween The Moncton Hospital Progression of type 2 diabetes Beta cell apoptosis Natural History of Type 2 Diabetes The Burden of Treatment Failure
More informationTarget Audience. approach this patient case scenario, including identifying an
Activity Overview In this case-based webcast, meet LaWanda, a 57-year-old woman with type 2 diabetes. Her glycated hemoglobin (HbA1C) is 8.4%, she is currently taking basal insulin and fast-acting insulin,
More information7/8/2016. Sol Jacobs MD, FACE Division of Endocrinology Emory University School of Medicine
Sol Jacobs MD, FACE Division of Endocrinology Emory University School of Medicine Participation in investigator initiated clinical research supported by: Merck Boehringer Ingelheim Novo Nordisk Astra Zeneca
More informationTHYROTOXICOSIS DR.J.BALA KUMAR 2 ND YR SURGERY PG
THYROTOXICOSIS DR.J.BALA KUMAR 2 ND YR SURGERY PG What is the difference between thyrotoxicosis and hyperthyroidism Thyrotoxicosis Thyrotoxicosis is defined as the state of thyroid hormone excess and is
More informationThursday School 2010 Management of Inpatient Diabetes and Hyperglycemia and Quality Improvement Efforts
Thursday School 2010 Management of Inpatient Diabetes and Hyperglycemia and Quality Improvement Efforts Kendall Rogers, MD Using subcutaneous insulin to reliably achieve desired glycemic outcomes in non-critically
More informationInsulin 10/11/17. Disclosures. Objectives. Speaker and Consultant for Jansen and Healthscripts Speaker and Consultant for Boehringer Ingelheim (BI)
Insulin The What, When, Where, Who and Why Disclosures Speaker and Consultant for Jansen and Healthscripts Speaker and Consultant for Boehringer Ingelheim (BI) Objectives Define background and history
More informationManagement of Inpatient Hyperglycemia: 2011 Endocrine Society Meeting Hyperglycemia in Critically ill patients in ICU Settings.
Management of Inpatient Hyperglycemia: 2011 Endocrine Society Meeting Guillermo E. Umpierrez, MD, Emory University School of Medicine and Jack Leahy, MD, University of Connecticut Hyperglycemia in Critically
More information4/10/2015. Foundations to Managing Inpatient Hyperglycemia. Learning Objectives
Foundations to Managing Inpatient Hyperglycemia Module A 1 Learning Objectives Develop strategies to identify patients with hyperglycemia or diabetes in the inpatient setting Establish glycemic goals to
More informationINSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE
INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE OBJECTIVES DESCRIBE INSULIN, INCLUDING WHERE IT COMES FROM AND WHAT IT DOES STATE THAT
More informationSupplementary Online Content
Supplementary Online Content Won EJ, Lehman EB, Geletzke AK, et al. Association of postoperative hyperglycemia with outcomes among patients with complex ventral hernia repair. JAMA Surg. Published online
More informationINSULIN 101: When, How and What
INSULIN 101: When, How and What Alice YY Cheng @AliceYYCheng Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form
More informationDisclosures. Glycemic Control in the Intensive Care Unit. Objectives. Hyperglycemia. Hyperglycemia. History. No disclosures
Disclosures Glycemic Control in the Intensive Care Unit No disclosures Jorie Frasiolas, Pharm.D., BCPS Clinical Pharmacy Manager, CTICU NewYork-Presbyterian Hospital Columbia University Medical Center
More informationUpdate on New Basal Insulins and Combinations: Starting, Titrating and Adding to Therapy
Update on New Basal Insulins and Combinations: Starting, Titrating and Adding to Therapy Jerry Meece, BPharm, CDE, FACA, FAADE Director of Clinical Services Plaza Pharmacy and Wellness Center Gainesville,
More informationA Children s Bedtime Story
A Children s Bedtime Story Setting: University Medical Center, Big Town, USA Scenario: 0500, last admission of the night, 10 previous admissions, all tucked in for the night Patient: 75 year old male with
More informationWhat s so sweet about glycemic control? June 3, 2016
What s so sweet about glycemic control? June 3, 2016 Objectives Provide an overview of why glucose control is important in surgical patient outcomes. Demonstrate an understanding of how anesthetics and
More information123 Are You Providing Evidence-Based Diabetes Care? - Martin
Donna Martin, DNP, RN, CDE, CMSRN Lewis University Learner will be able to: Identify current inpatient standards of care for patients with diabetes Describe causes of hyperglycemia / hypoglycemia in the
More information4) Thyroid Gland Defects - Dr. Tara
4) Thyroid Gland Defects - Dr. Tara Thyroid Pituitary Axis TRH secreted in the hypothalamus stimulates production and Secretion of TSH TSH stimulates secretion of T3, T4 T4 has negative feedback on secretion
More informationBasal-Bolus Insulin Therapy. Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January
Basal-Bolus Insulin Therapy Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January 18 2018 Terminology No longer using the term diabetic. Diabetes does not define people. People with diabetes are individuals
More informationLecture title. Name Family name Country
Lecture title Name Family name Country Nguyen Thy Khue, MD, PhD Department of Endocrinology HCMC University of Medicine and Pharmacy, MEDIC Clinic Hochiminh City, Viet Nam Provided no information regarding
More informationHyperthyroidism Diagnosis and Treatment. April Janet A. Schlechte, M.D.
Hyperthyroidism Diagnosis and Treatment Family Practice Refresher Course April 2015 Janet A. Schlechte, M.D. Disclosure of Financial Relationships Janet A. Schlechte, M.D. has no relationships with any
More informationManagement: How Can We Do Better? Lori B. Sweeney, MD 2018 Virginia ACP Clinical Update March 17, 2018
Management: How Can We Do Better? Lori B. Sweeney, MD 2018 Virginia ACP Clinical Update March 17, 2018 Disclosures I have no Objectives Use a case-based format to discuss diabetes management pearls Discuss
More informationThyroid gland defects. Dr. Tara Husain
Thyroid gland defects Dr. Tara Husain Thyroid Pituitary Axis TRH secreted in the hypothalamus stimulates production and Secretion of TSH TSH stimulates secretion of T3,T4 T4 has negative feed back on secretion
More informationGlucose Management in the ICU: The Role of the Pharmacist
Objectives Glucose Management in the ICU: The Role of the Pharmacist James Gilmore PharmD, BCPS Senior Pharmacist- Surgical Intensive Care Unit Brigham and Women s Hospital Boston, MA Evaluate primary
More informationFasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period
Fasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period Dr Ketan Dhatariya MBBS MSc MD MS FRCP Consultant in Diabetes and Endocrinology Norfolk and Norwich
More informationSection of Endocrinology, Rush University Medical Center, Chicago, Illinois.
ORIGINAL RESEARCH Treatment of Inpatient Hyperglycemia Beginning in the Emergency Department: A Randomized Trial Using Insulins Aspart and Detemir Compared With Usual Care Jennifer B. Bernard, MD Christina
More informationCHALLENGING CASE PRESENTATION Steroid Induced Hyperglycemia
CHALLENGING CASE PRESENTATION Steroid Induced Hyperglycemia Javier Carrasco, MD, PhD Juan Ramón Jiménez Hospital University of Huelva, Spain Case Study: Medical and Social History A 60 years old female
More informationReceived: 23 September Accepted: 17 October 2009
ORIGINAL ARTICLE Comparing Effects of Continuous Insulin Infusion with or without Subcutaneous Glargine Insulin on Glycemic Control in Diabetic Patients Undergoing Coronary Artery Bypass Graft (CABG) Seyed
More informationNew Therapies for Diabetes Management: Hope or Headache?
New Therapies for Diabetes Management: Hope or Headache? Elizabeth Stephens, MD, FACP PMG- Endocrinology Elizabeth.Stephens@providence.org November 2018 Disclosures None 1 Objectives Discussion of 3 rd
More informationAACN PCCN Review. Endocrine
AACN PCCN Review Endocrine Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com Endocrine I. INTRODUCTION Disorders
More informationDKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014
DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol Glycemic Task Force September 2014 Hyperglycemic Crises: Pathophysiology DKA HHS Hyperglycemia DKA HHS Umpierrez, In Shoemaker,
More informationHYPOTHYROIDISM AND HYPERTHYROIDISM
HYPOTHYROIDISM AND HYPERTHYROIDISM SHAHIDA PERVEEN, AMBREEN Post RN BSCN Semester II FACULTY SIR RAJA April 13, 016 Objectives: State the functions of thyroid hormone. Understand the pathologic mechanism
More information8/13/2016. Insulin Basics. Rapid-Acting Insulin Analogs. Current Insulin Products and Pens. Basal Insulin Analogs. History of Insulin Therapy
Insulin Basics Anabolic hormone involved in metabolism Following carbohydrate ingestion insulin release is stimulated Suppresses hepatic glucose production Stimulates peripheral glucose uptake Commercially-available
More informationANNUAL MEETING 2 #FSHP2017
FSHP Disclosure Strategies for Glycemic Management in the Inpatient Setting: Guidelines vs. Reality Melissa Marshall, PharmD, BCPS Jeffrey Ruff, PharmD We do not have (nor does any immediate family member
More informationChallenges in Perioperative Medication Management. Learning Objectives. Case 1. » Appropriate use of beta-blockers. Management of diabetes drugs
Challenges in Perioperative Medication Management Dimitriy Levin, MD Assistant Professor of Medicine University of Colorado Hospital Medicine Group Learning Objectives» Appropriate use of beta-blockers
More information5/16/2018. Insulin Update: New and Emerging Insulins. Disclosures to Participants. Learning Objectives
Insulin Update: New and Emerging Insulins Joshua J. Neumiller, PharmD, CDE, FASCP Vice Chair & Associate Professor, Department of Pharmacotherapy Washington State University Spokane, WA Disclosures to
More informationNew basal insulins Are they any better? Matthew C. Riddle, MD Professor of Medicine Oregon Health & Science University Keystone Colorado 15 July 2011
New basal insulins Are they any better? Matthew C. Riddle, MD Professor of Medicine Oregon Health & Science University Keystone Colorado 15 July 2011 Presenter Disclosure I have received the following
More informationSelf-Monitoring Blood Glucose (SMBG) Frequency & Pattern Tool
Self-Monitoring Blood Glucose () Pattern Recommendation: Basal Insulin Only (To Target) NPH or long-acting analogue, typically given at. at least as often as is being given. Optional, less frequent can
More informationRebecca Newberry APRN MS CDE
Current Diabetes Medications Nursing Implications and Applications Rebecca Newberry APRN MS CDE Methodist Center for Diabetes and Nutritional Health Disclosures Objectives Speakers Bureaus/Consulting Board
More informationThe Portland Diabetic Project: Hyperglycemia/Mortality Hypothesis
The Portland Diabetic Project: Hyperglycemia/Mortality Hypothesis Perioperative Hyperglycemia increases the risk of mortality in patients undergoing CABG. (n = 3956) 6.1% 4.9% The Portland Diabetic Project
More informationTHE CURRENT APPROACH TO T1D IN CHILDREN
THE CURRENT APPROACH TO T1D IN CHILDREN Dina Panagiotopoulos, MD, FRCPC Associate Professor, Department of Pediatrics University of British Columbia Endocrinologist, BC Children s Hospital CFRI & CDA Clinician
More information